BSE filing, NSE: MEESHO. Summary written from the filing by ALFA Finder's alert engine.
Meesho Ltd: key numbers
- Share price
- ₹227.84
- Market cap
- ₹1,05,464 Cr
- Revenue (annual)
- ₹12,626 Cr
- Net profit (annual)
- ₹-1,358 Cr
- P/E (TTM)
- -114.3×Sector 61.5×
- Promoter holding
- 16.34%-0.07% QoQ
- FII holding
- 9.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Meesho Ltd
All →Meesho Capital Structure Change
Meesho approved up to Rs.400 Crore capital infusion into its wholly owned subsidiary, Meesho Payments. Board also approved a new subsidiary and further Kirana Club investments.
- Value
- ₹400.0 Cr
Meesho Earnings Call Transcript: Key Takeaways
Meesho reported strong contribution margins driven by logistics efficiencies, but higher server costs and seasonal marketing spends limited overall operating leverage.
Meesho Other Announcement
Meesho filed its IPO monitoring agency report for the quarter ended September 2026. It shows no deviation from IPO objects, so this is routine compliance.
Meesho Results Update
Meesho reported Q2 FY27 NMV growth of 23% and narrowed net losses by 68% to ₹132 crore. Contribution margin rose to 6.0% of NMV.
Meesho Business Update
Meesho's Q2 FY27 shareholders' letter reports NMV up 23% YoY to ₹12,911 crore. Festive timing moved the Mega Blockbuster Sale into Q3.
Meesho Q2 FY27 Results: Net Loss of ₹132.4 Cr, Loss Narrows
Meesho Ltd reported revenue from operations of ₹4,132 Cr (+34.4% YoY) and a net loss of ₹132.4 Cr for Q2 FY27.
- Key figure
- Net loss ₹132.4 Cr
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.